http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3027178-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
filingDate 2017-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ec5b4e14de33dc72a3f14132f873b60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f020d7405292462eb7ef54c425b2cf8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92d6007a3217d9e30936b98169a36563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d5a25584eb448eb0d3757b1a83d5424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_869e18f6c81379feef430edaaf3d0c29
publicationDate 2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3027178-A1
titleOfInvention Anti-egfr antibody drug conjugates
abstract The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs. Formula (IIa), (IIb), (IIc)
priorityDate 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466248835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466250518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424598140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467585365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467397469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466251814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468007907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7811

Total number of triples: 43.